Sign inGet started

von Moltke Lisa

Insider CIK 1808592 · CARA Director · MCRB See Remarks · ZBIO See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZBIO Zenas BioPharma, Inc. A Award deriv2026-06-152026-06-17150,000— $0150,000SEC↗
ZBIO Zenas BioPharma, Inc. A Award deriv2025-04-152025-04-17400,000— $0400,000SEC↗
MCRB Seres Therapeutics, Inc. S Sale2025-02-182025-02-194,416$0.81 $3.6K39,875SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2025-02-152025-02-198,907— $026,718SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2025-02-152025-02-192,969— $023,750SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2025-02-152025-02-192,969— $035,384SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2025-02-152025-02-198,907— $044,291SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2025-02-072025-02-11650,000— $0650,000SEC↗
MCRB Seres Therapeutics, Inc. S Sale2024-11-182024-11-19977$0.54 $52832,415SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2024-11-152024-11-192,969— $026,719SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2024-11-152024-11-192,969— $033,392SEC↗
MCRB Seres Therapeutics, Inc. S Sale2024-10-282024-10-294,334$0.69 $3.0K30,423SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2024-10-272024-10-2913,744— $00SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2024-10-272024-10-2913,744— $034,757SEC↗
MCRB Seres Therapeutics, Inc. S Sale2024-08-162024-08-19973$0.84 $81721,013SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2024-08-152024-08-192,969— $029,688SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2024-08-152024-08-192,969— $021,986SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2024-06-042024-06-06195,000— $0195,000SEC↗
CARA Cara Therapeutics, Inc. A Award2024-06-042024-06-06150,647— $0183,009SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2024-05-152024-05-172,968— $032,657SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2024-05-152024-05-172,968— $019,956SEC↗
MCRB Seres Therapeutics, Inc. S Sale2024-05-152024-05-17939$0.94 $88319,017SEC↗
MCRB Seres Therapeutics, Inc. S Sale2024-02-162024-02-164,400$1.08 $4.8K16,988SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2024-02-152024-02-1611,875— $035,625SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2024-02-152024-02-1611,875— $021,388SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2024-02-142024-02-16213,750— $0213,750SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2024-02-142024-02-1635,625— $035,625SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2024-02-142024-02-16287,905— $0287,905SEC↗
MCRB Seres Therapeutics, Inc. S Sale2023-10-302023-10-314,232$1.35 $5.7K9,513SEC↗
MCRB Seres Therapeutics, Inc. M Exercise deriv2023-10-272023-10-3113,745— $013,744SEC↗
MCRB Seres Therapeutics, Inc. M Exercise2023-10-272023-10-3113,745— $013,745SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2023-06-012023-06-0544,961— $044,961SEC↗
CARA Cara Therapeutics, Inc. A Award2023-06-012023-06-0532,362— $032,362SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2023-04-272023-10-3127,489— $027,489SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2023-02-032023-02-0747,500— $047,500SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2023-02-032023-02-0795,000— $095,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2023-01-022023-01-1945,841— $045,841SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2022-02-042022-02-08175,000— $0175,000SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2021-02-042021-02-08110,000— $0110,000SEC↗
MCRB Seres Therapeutics, Inc. A Award deriv2020-04-062020-04-07325,000— $0325,000SEC↗